Multiple-variable dose regimen for treating TNFalpha-related disorders

Details for Australian Patent Application No. 2005244261 (hide)

Owner Abbott Biotechnology Ltd

Inventors Chartash, Elliot; Granneman, George Richard; Hoffman, Rebeca S.; Taylor, Lori K.; Yan, Philip

Agent Spruson & Ferguson

Pub. Number AU-B-2005244261

PCT Pub. Number WO2005/110452

Priority 60/561,139 09.04.04 US; 60/569,100 07.05.04 US; 60/561,710 12.04.04 US

Filing date 11 April 2005

Wipo publication date 24 November 2005

Acceptance publication date 22 September 2011

International Classifications

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 39/40 (2006.01) Medicinal preparations containing antigens or antibodies - bacterial

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

Event Publications

26 October 2006 PCT application entered the National Phase

  PCT publication WO2005/110452 Priority application(s): WO2005/110452

22 September 2011 Application Accepted

  Published as AU-B-2005244261

19 January 2012 Opposition Lodged

  Alphapharm Pty Ltd has lodged an opposition against Abbott Biotechnology Ltd.

5 April 2012 Opposition Withdrawn

  The opposition by Alphapharm Pty Ltd against Abbott Biotechnology Ltd has been withdrawn.

12 April 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005244262-Nucleotide-cochleate compositions and methods of use

2005244260-Methods, compositions, and preparations for delivery of immune response modifiers